Bank Of New York Mellon Corp Protara Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.43 - $3.7 $43,514 - $66,255	17,907 New	17,907 $47,000
Q2 2021 Aug 11, 2021	SELL	$8.68 - $16.99 $67,513 - $132,148	-7,778 Reduced 30.28%	17,907 $0
Q1 2021 May 13, 2021	BUY	$13.75 - $23.86 $7,466 - $12,955	543 Added 2.16%	25,685 $0
Q4 2020 Feb 09, 2021	BUY	$16.97 - $25.34 $426,659 - $637,098	25,142 New	25,142 $0

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $34.3M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.